(Q38442169)

English

Adjuvant system AS02V enhances humoral and cellular immune responses to pneumococcal protein PhtD vaccine in healthy young and older adults: randomised, controlled trials

scientific article published on 29 October 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Adjuvant system AS02V enhances humoral and cellular immune responses to pneumococcal protein PhtD vaccine in healthy young and older adults: randomised, controlled trials (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Geert Leroux-Roels

3

object named as

Geert Leroux-Roels

0 references

author name string

Isabel Leroux-Roels

1

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Jeanne-Marie Devaster

2

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Vincent Verlant

4

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Isabelle Henckaerts

5

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Philippe Moris

6

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Philippe Hermand

7

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Pascale Van Belle

8

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Jan T Poolman

9

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Pierre Vandepapelière

10

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Yves Horsmans

11

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

language of work or name

0 references

publication date

29 October 2013

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

33

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

577-584

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Immunosenescence: what does it mean to health outcomes in older adults?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.052

7 January 2021

Aging and impaired immunity to influenza viruses: implications for vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.052

7 January 2021

Hepatitis B vaccination of susceptible elderly residents of long term care facilities during a hepatitis B outbreak

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.052

7 January 2021

Effectiveness of pneumococcal polysaccharide vaccine in older adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.052

7 January 2021

Efficacy of pneumococcal vaccination in adults: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.052

7 January 2021

Editorial commentary: should 13-valent protein-conjugate pneumococcal vaccine be used routinely in adults?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.052

7 January 2021

Is there a potential role for protein-conjugate pneumococcal vaccine in older adults?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.052

7 January 2021

Pneumococcal conjugate and plain polysaccharide vaccines have divergent effects on antigen-specific B cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.052

7 January 2021

Are anticapsular antibodies the primary mechanism of protection against invasive pneumococcal disease?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.052

7 January 2021

Antibody and cell-mediated immunity to Streptococcus pneumoniae: implications for vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.052

7 January 2021

Next generation pneumococcal vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.052

7 January 2021

Serotype-independent pneumococcal experimental vaccines that induce cellular as well as humoral immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.052

7 January 2021

Acquisition of pneumococci specific effector and regulatory Cd4+ T cells localising within human upper respiratory-tract mucosal lymphoid tissue.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.052

7 January 2021

T(H)17-based vaccine design for prevention of Streptococcus pneumoniae colonization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.052

7 January 2021

Identification and characterization of a novel family of pneumococcal proteins that are protective against sepsis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.052

7 January 2021

Preclinical evaluation of the Pht proteins as potential cross-protective pneumococcal vaccine antigens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.052

7 January 2021

Vaccine candidates PhtD and PhtE of Streptococcus pneumoniae are adhesins that elicit functional antibodies in humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.052

7 January 2021

A protein-based pneumococcal vaccine protects rhesus macaques from pneumonia after experimental infection with Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.052

7 January 2021

Age-related changes in immunity: implications for vaccination in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.052

7 January 2021

Vaccine adjuvant systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.052

7 January 2021

Tracking human antigen-specific memory B cells: a sensitive and generalized ELISPOT system

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.052

7 January 2021

Cross-regulation of signaling pathways by interferon-gamma: implications for immune responses and autoimmune diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.052

7 January 2021

IL-2 family cytokines: new insights into the complex roles of IL-2 as a broad regulator of T helper cell differentiation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.052

7 January 2021

Insights into the initiation of type 2 immune responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.052

7 January 2021

Effect of cilomilast (Ariflo) on TNF-alpha, IL-8, and GM-CSF release by airway cells of patients with COPD.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.052

7 January 2021

The role of CD40 and CD154/CD40L in dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.052

7 January 2021

Innate control of B cell responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.052

7 January 2021

A live-cell assay to detect antigen-specific CD4+ T cells with diverse cytokine profiles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.052

7 January 2021

Direct access to CD4+ T cells specific for defined antigens according to CD154 expression.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.052

7 January 2021

Granulocyte-macrophage colony-stimulating factor (GM-CSF) and T-cell responses: what we do and don't know

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.052

7 January 2021

Immunofluorescence analysis of T-cell responses in health and disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.052

7 January 2021

H5N1 influenza vaccine formulated with AS03 A induces strong cross-reactive and polyfunctional CD4 T-cell responses.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.052

7 January 2021

Strong and persistent CD4+ T-cell response in healthy adults immunized with a candidate HIV-1 vaccine containing gp120, Nef and Tat antigens formulated in three Adjuvant Systems.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.052

7 January 2021

Recent clinical experience with vaccines using MPL- and QS-21-containing adjuvant systems

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.052

7 January 2021

Regulation of aged humoral immune defense against pneumococcal bacteria by IgM memory B cell.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.052

7 January 2021

Age-Related Changes in Human Peripheral Blood IGH Repertoire Following Vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.052

7 January 2021

Why aging T cells fail: implications for vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.052

7 January 2021

CD4-T-lymphocyte interactions with pneumolysin and pneumococci suggest a crucial protective role in the host response to pneumococcal infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.052

7 January 2021

Effect of serotype on focus and mortality of invasive pneumococcal disease: coverage of different vaccines and insight into non-vaccine serotypes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.052

7 January 2021

Identifiers

10.1016/J.VACCINE.2013.10.052

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38442169&oldid=1760083035"